Beijing Cancer Prevention & Treatment Society

This study is for people with advanced non-small cell lung cancer who have a specific genetic change (EGFR mutation). It tests if adding two chemotherapy drugs (carboplatin and pemetrexed) to the standard targeted drug osimertinib works better than taking osimertinib alone. The t…